ArticleEuropean journal of nuclear medicine and molecular imaging2011

Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours.

Rosalba Mansi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.